Ronit Capital LLP Nuvectis Pharma, Inc. Call Options Transaction History
Ronit Capital LLP
- $74.3 Million
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCT
# of Institutions
38Shares Held
2.63MCall Options Held
116KPut Options Held
87.6K-
Vanguard Group Inc Valley Forge, PA467KShares$3.78 Million0.0% of portfolio
-
Baldwin Brothers LLC350KShares$2.83 Million0.19% of portfolio
-
Iridian Asset Management LLC254KShares$2.05 Million0.82% of portfolio
-
Geode Capital Management, LLC Boston, MA135KShares$1.09 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny121KShares$978,4960.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $118M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...